Elevance Health (ELV)

EBITDA

$2.36B

Quarterly · Period ending: · USD

ELV logo

ELV EBITDA

Latest reported$2.36B
ELV Quarterly EBITDA ($0.00 → $2.36B)
High-resolution chart · PNG

ELV ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Elevance Health EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
2,359,000,000
3,015,000,000
987,000,000
2,144,000,000
3,013,000,000
3,514,000,000
1,344,000,000
2,002,000,000
3,601,000,000
3,535,000,000
1,684,000,000
2,339,000,000
3,135,000,000
3,332,000,000
1,747,000,000
2,791,000,000
2,723,000,000
2,865,000,000
1,960,000,000
2,548,000,000
2,867,000,000
2,650,000,000
1,092,000,000
895,000,000
3,636,000,000
2,553,000,000
1,534,000,000
1,975,000,000
1,934,000,000
2,421,000,000
1,020,000,000
1,718,000,000
1,981,200,000
2,234,500,000
287,800,000
1,492,900,000
1,395,600,000
1,750,000,000
908,800,000
1,382,800,000
1,859,800,000
1,724,400,000
785,300,000
1,265,200,000
2,203,600,000
1,937,800,000
1,248,800,000
1,450,600,000
1,627,400,000
1,493,000,000
843,300,000
1,262,300,000
1,588,000,000
1,648,000,000
826,000,000
1,346,200,000
1,348,200,000
1,597,600,000
770,600,000
1,305,300,000
1,265,800,000
1,683,700,000
1,387,700,000
1,398,900,000
1,377,000,000
1,574,200,000
4,471,800,000
1,254,200,000
1,195,700,000
1,035,800,000
650,400,000
694,600,000
1,328,600,000
1,024,000,000
1,592,200,000
1,519,400,000
1,448,700,000
1,381,000,000
1,538,500,000
1,511,800,000
1,570,900,000
1,301,600,000
1,255,900,000
1,109,300,000
991,900,000
1,005,200,000
456,400,000
464,800,000
457,500,000
482,000,000
421,800,000
408,200,000
373,500,000
391,800,000
358,500,000
304,800,000
204,200,000
46,100,000
163,900,000
199,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.